In one paragraphArticle in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
17 authors.
Emma DereskewiczDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0009-0009-1177-2886 Francesco La RosaDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0002-9224-4664 Jonadab Dos Santos SilvaDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0002-4216-333X Edward SizerDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0001-6288-2844 Amit KohliDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
William A MullinsTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Sarah LevyDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0002-8254-2553 Kamso OnyemehDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Batuhan AyciDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0003-3418-7822 Andrew J SolomonDepartment of Neurology, University of Vermont, Burlington, VT.
Jakob AssländerCenter for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, NY, USA.ORCID 0000-0003-2288-038X Omar Al-LouziTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2260-5660 Daniel S ReichTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2628-4334 James SumowskiDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0001-6111-4907 Erin S BeckDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0001-7839-7958 Funding
Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4MTR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical careP41EB017183 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Christopher M Collins · 2014 to 2026
$19.3MCOVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0MBig Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0MQuantification of Multi-Compartment T1 Relaxation and Magnetization Transfer in Biological Tissue: From Biophysics to Biomarkers for Multiple SclerosisR01NS131948 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Jakob Asslaender · 2024 to 2026
$1.8MComputational Model of Neurocognitive Impairment in Multiple SclerosisR01NS136523 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Joshua Sandry, James Francis Sumowski · 2025 to 2026
$1.2MNCATS NIH HHS UL1 TR004419NIBIB NIH HHS P41 EB017183NIH HHS S10 OD026880NIH HHS S10 OD030463NINDS NIH HHS R01 NS131948NINDS NIH HHS R01 NS136523
6 · The paper itselfAbstract
Background and Purpose: Assessment of brain lesions on MRI is crucial for research in multiple sclerosis (MS). Manual segmentation is time consuming and inconsistent. We aimed to develop an automated MS lesion segmentation algorithm for T2-weighted fluid-attenuated inversion recovery (FLAIR) MRI. Methods: We developed FLAIR Lesion Analysis in Multiple Sclerosis (FLAMeS), a deep learning-based MS lesion segmentation algorithm based on the nnU-Net 3D full-resolution U-Net and trained on 668 FLAIR 1.5 and 3 tesla scans from persons with MS. FLAMeS was evaluated on three external datasets: MSSEG-2 (n=14), MSLesSeg (n=51), and a clinical cohort (n=10), and compared to SAMSEG, LST-LPA, and LST-AI. Performance was assessed qualitatively by two blinded experts and quantitatively by comparing automated and ground truth lesion masks using standard segmentation metrics. Results: In a blinded qualitative review of 20 scans, both raters selected FLAMeS as the most accurate segmentation in 15 cases, with one rater favoring FLAMeS in two additional cases. Across all testing datasets, FLAMeS achieved a mean Dice score of 0.74, a true positive rate of 0.84, and an F1 score of 0.78, consistently outperforming the benchmark methods. For other metrics, including positive predictive value, relative volume difference, and false positive rate, FLAMeS performed similarly or better than benchmark methods. Most lesions missed by FLAMeS were smaller than 10 mm Conclusions: FLAMeS is an accurate, robust method for MS lesion segmentation that outperforms other publicly available methods.
Identifiers
PMID40475145
PMCPMC12140514
What OpenQuestion holds
Textmetadata
LicenceCC BY-ND
Read underepoch 390